Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jul 18:11:1199728.
doi: 10.3389/fpubh.2023.1199728. eCollection 2023.

Caries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial

Elzbieta Paszynska  1 , Malgorzata Pawinska  2 , Joachim Enax  3 , Frederic Meyer  3 , Erik Schulze Zur Wiesche  3 , Theodor W May  4 , Bennett T Amaechi  5 , Hardy Limeback  6 , Amadeusz Hernik  1 , Justyna Otulakowska-Skrzynska  1 , Anna Krahel  1 , Inga Kaminska  2 , Joanna Lapinska-Antonczuk  2 , Ewa Stokowska  7 , Maria Gawriolek  1
Affiliations
Randomized Controlled Trial

Caries-preventing effect of a hydroxyapatite-toothpaste in adults: a 18-month double-blinded randomized clinical trial

Elzbieta Paszynska et al. Front Public Health. .

Abstract

Background: Dental caries is a worldwide challenge for public health. The aim of this 18-month double-blinded, randomized, clinical trial was to compare the caries-preventing effect of a fluoride-free, hydroxyapatite toothpaste (test) and a toothpaste with sodium fluoride (1450 ppm fluoride; positive control) in adults.

Methods: The primary endpoint was the percentage of subjects showing no increase in overall Decayed Missing Filled Surfaces (DMFS) index. The study was designed as non-inferiority trial. Non-inferiority was claimed if the upper limit of the exact one-sided 95% confidence interval for the difference of the primary endpoint DMFS between test and control toothpaste was less than the predefined margin of non-inferiority (Δ ≤ 20%).

Results: In total, 189 adults were included in the intention-to-treat (ITT) analysis; 171 subjects finished the study per protocol (PP). According to the PP analysis, no increase in DMFS index was observed in 89.3% of subjects of the hydroxyapatite group and 87.4% of the subjects of the fluoride group. The hydroxyapatite toothpaste was not statistically inferior to a fluoride toothpaste with regard to the primary endpoint.

Conclusion: Hydroxyapatite was proven to be a safe and efficient anticaries agent in oral care.

Clinical trial registration: NCT04756557.

Keywords: Decayed Missing Filled Surfaces (DMFS) index; adults; dental caries; fluoride; hydroxyapatite; public health; randomized clinical trial (RCT); toothpaste.

PubMed Disclaimer

Conflict of interest statement

JE, FM, and ESc are employees of Dr. Kurt Wolff GmbH and Co. KG, Bielefeld, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Patient flow chart.
Figure 2
Figure 2
Mean values (and 95% confidence intervals) of differences between DMFS V2 - V1, DMFS V3 - V1, and DMFS V4 - V1 differentiated by group (control vs. test toothpaste).
Figure 3
Figure 3
Subjects (%) with an increase in DMFS differentiated by group (control vs. test toothpaste).
Figure 4
Figure 4
Boxplots of NCL% at V1 and V4 differentiated by group (control vs. test toothpaste).
Figure 5
Figure 5
Boxplots of PCR Index (number of plaque-containing surfaces/total number of available surfaces) at visits V1, V2, V3, and V4 differentiated by group (control vs. test toothpaste).
See this image and copyright information in PMC

References

    1. Dorozhkin SV, Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed. (2002) 41:3130–46. 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 - DOI - PubMed
    1. Mohd Pu'ad NAS, Abdul Haq RH, Mohd Noh H, Abdullah HZ, Idris MI, Lee TC. Synthesis method of hydroxyapatite: a review. Mater Today Proc. (2020) 29:233–9. 10.1016/j.matpr.2020.05.536 - DOI
    1. Enax J, Meyer F, Schulze zur Wiesche E, Epple M. On the application of calcium phosphate micro- and nanoparticles as food additive. Nanomaterials. (2022) 12:4075. 10.3390/nano12224075 - DOI - PMC - PubMed
    1. Brown PW, Constantz B. Hydroxyapatite and Related Materials. Boca Raton: CRC Press. (1994).
    1. Epple M. Review of potential health risks associated with nanoscopic calcium phosphate. Acta Biomater. (2018) 77:1–14. 10.1016/j.actbio.2018.07.036 - DOI - PubMed

Publication types

Associated data